Published in Am J Pathol on January 01, 2003
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int J Mol Sci (2012) 1.15
Pathological bases for a robust application of cancer molecular classification. Int J Mol Sci (2015) 0.79
Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet (1999) 3.30
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res (2001) 2.06
Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. J Natl Cancer Inst (1999) 1.44
Unknown primary head and neck squamous cell carcinoma: molecular identification of the site of origin. J Natl Cancer Inst (1999) 1.13
Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin Cancer Res (1999) 1.09
X chromosome inactivation in the normal female genital tract: implications for identification of neoplasia. Cancer Res (1995) 0.95
Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity. Mod Pathol (1997) 0.92
Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia. J Clin Endocrinol Metab (2001) 0.91
PCR techniques for clonality assays. Diagn Mol Pathol (2001) 0.90
Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder. Lab Invest (2000) 0.86
Molecular clonality of in-transit melanoma metastasis. Am J Pathol (2001) 0.86
Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex. Am J Pathol (2000) 0.82
Clonality Studies in the Analysis of Adrenal Medullary Proliferations: Application Principles and Limitations. Endocr Pathol (1998) 0.81
Are PCR artifacts in microdissected samples preventable? Hum Pathol (2001) 0.80
Designing a molecular analysis of clonality in tumours. J Pathol (2000) 0.80
Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes. Am J Clin Pathol (2002) 0.80
Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates. J Pathol (2000) 0.79
Influence of intratumour heterogeneity in the interpretation of marker results in phaeochromocytomas. J Pathol (1999) 0.79
RAS testing of colorectal carcinoma—a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group. J Clin Pathol (2014) 1.07
Dermoscopy of trichostasis spinulosa. Arch Dermatol (2008) 0.86
Thyroid nodule with arteriovenous malformation: under-recognized cause of increased vascularity. Histol Histopathol (2013) 0.82
Microsatellite instability in colon cancer. N Engl J Med (2003) 0.81
Kinetic profiles by topographic compartments in muscle-invasive transitional cell carcinomas of the bladder: role of TP53 and NF1 genes. Am J Clin Pathol (2002) 0.80
Topographic molecular profile of pheochromocytomas: role of somatic down-regulation of mismatch repair. J Clin Endocrinol Metab (2006) 0.78
DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions. Hum Pathol (2006) 0.78
Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas. World J Gastroenterol (2006) 0.77
Coexistent intraurothelial carcinoma and muscle-invasive urothelial carcinoma of the bladder: clonality and somatic down-regulation of DNA mismatch repair. Hum Pathol (2009) 0.76
Molecular mechanisms in melanoma. N Engl J Med (2006) 0.76
Histologic criteria for adrenocortical proliferative lesions: value of mitotic figure variability. Am J Clin Pathol (2007) 0.76
Heterogeneous topographic profiles of kinetic and cell cycle regulator microsatellites in atypical (dysplastic) melanocytic nevi. Mod Pathol (2011) 0.75
Motesanib diphosphate in progressive differentiated thyroid cancer. N Engl J Med (2008) 0.75
Difference between familial and sporadic medullary thyroid carcinomas. Am J Surg Pathol (2003) 0.75
Adrenocortical adenomas with regression and myelolipomatous changes: urinary steroid profiling supports a distinctive benign neoplasm. Clin Endocrinol (Oxf) (2014) 0.75
Multilobated abdominal nodule. Arch Dermatol (2002) 0.75